Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R...
Get real-time Alnylam Pharmaceuticals (0HD2) stock price quotes, analyst insights, forecasts, news, and information you need to help your stock trading and investing.
FinancialsDividendsEarningsPrice HistoryEventsInsiders Alnylam Pharmaceuticals Inc. News Investing News, Analysis, and Tips Dec 14, 2022 7:22 PM EST This Genetic Medicine Stock Soared Over 50% on Industry First Avidity Biosciences roared higher after announcing favorable data delivering RNA medicines to ...
Get Alnylam Pharmaceuticals Inc (ALNY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
ALNY Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +44.76% Alnylam Pharmaceuticals, Inc. price and volume Combination chart with 2 data series. Chart represents Alnylam Pharmaceuticals, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The...
Currently, Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for the last month. ...
Find the latest Alnylam Pharmaceuticals, Inc. Common Stock (ALNY) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.
Discover real-time Alnylam Pharmaceuticals, Inc. Common Stock (ALNY) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.
Alnylam Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
HC Wainwright & Co.:重申Alnylam Pharmaceuticals(ALNY.US)评级,由买入调整至买入评级, 目标价由400.00美元调整至500.00美元。 阿里拉姆制药(ALNY.US)公司简介:艾拉伦制药是RNA干扰(RNAi)治疗研究的领导者。RNA干扰(RNAi)是细胞内一种自然发生的生物通路,用于序列特异性沉默和调控基因表达。艾拉伦有5种药物上市:治疗...